Cordyceps Cicadae Polysaccharides Attenuate Diabetic Nephropathy Via the MiR-30a-3p/TRIM16 Axis

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2023 Dec 27

PMID 38149724

Authors

Rong Zheng

Qin Xu

Yiwen Wang

Yifei Zhong

Rong Zhu

Affiliations

Soon will be listed here.

Abstract

Objective: The molecular mechanism of the protective effect of Cordyceps cicadae polysaccharides (CCPs) on renal tubulointerstitial fibrosis in diabetic nephropathy (DN) is still unclear. This study aims to further understand the molecular mechanisms behind the therapeutic benefits of CCP on diabetic nephropathy.

Methods: Mice were randomly assigned into six groups (n = 8). Cordyceps cicadae polysaccharide dissolved in 5% dimethyl sulfoxide was administered by gavage for 12 consecutive weeks. The CCP doses were divided into low, medium, and high, 75, 150, and 300 mg/kg/day, respectively. The efficacy of CCP was determined by assessing the renal function and histological alterations in diabetic db/db mice. The degree of glomerular mesangial dilatation and sclerosis was evaluated using semiquantitative markers. Cell viability, apoptosis, epithelial-mesenchymal transition (EMT), inflammation, oxidative stress, and mitochondrial reactive oxygen species (ROS) in high glucose (HG)-cultured MPC5 podocytes were determined. The interaction of miR-30a-3p and tripartite motif-containing protein 16 (TRIM16) was examined by luciferase reporter assay. Western blotting, reverse transcription-polymerase chain reaction, and immunofluorescence were used to analyze gene and protein expressions.

Results: The in vivo findings illustrated that CCP may protect mice with type 2 diabetes from inflammation and oxidative damage (P < 0.05). Furthermore, CCP has a therapeutic value in protecting renal function and morphology in diabetic nephropathy by reversing podocyte EMT. The in vitro results indicated that CCP dose-dependently inhibited HG-induced apoptosis, EMT, inflammation, oxidative stress, and mitochondrial ROS levels in MPC5 podocytes (P < 0.05). Luciferase reporter assay confirmed the interaction between miR-30a-3p and TRIM16 in MPC5 podocytes cultured in high glucose (P < 0.05).

Conclusion: The protective effect of CCP on HG-induced MPC5 can be achieved by miR-30a-3p/TRIM16 axis.

Citing Articles

Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy.

Liu F, Yang Z, Li J, Wu T, Li X, Zhao L Mol Med. 2024; 30(1):265.

PMID: 39707216 PMC: 11660506. DOI: 10.1186/s10020-024-01020-5.

β-Sitosterol Mitigates Apoptosis, Oxidative Stress and Inflammatory Response by Inactivating TLR4/NF-кB Pathway in Cell Models of Diabetic Nephropathy.

Yang S, Zhang Y, Zheng C Cell Biochem Biophys. 2024; 83(1):1249-1262.

PMID: 39424766 DOI: 10.1007/s12013-024-01559-4.

Noncoding RNAs and diabetic kidney disease.

Wada J J Diabetes Investig. 2024; 16(1):8-9.

PMID: 39361944 PMC: 11693531. DOI: 10.1111/jdi.14331.

References

Joglekar M, Patil D, Joglekar V, Rao G, Reddy D, Mitnala S . The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets. 2010; 1(2):137-47. DOI: 10.4161/isl.1.2.9578. View

Wang E, Wang L, Ding R, Zhai M, Ge R, Zhou P . Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy. Pharmacol Res. 2020; 157:104831. DOI: 10.1016/j.phrs.2020.104831. View

Tang J, Yao D, Yan H, Chen X, Wang L, Zhan H . The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy. Int J Endocrinol. 2019; 2019:8719060. PMC: 6914872. DOI: 10.1155/2019/8719060. View

Strasser A, Cory S, Adams J . Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J. 2011; 30(18):3667-83. PMC: 3173800. DOI: 10.1038/emboj.2011.307. View

Mihailovic M, Dinic S, Arambasic Jovanovic J, Uskokovic A, Grdovic N, Vidakovic M . The Influence of Plant Extracts and Phytoconstituents on Antioxidant Enzymes Activity and Gene Expression in the Prevention and Treatment of Impaired Glucose Homeostasis and Diabetes Complications. Antioxidants (Basel). 2021; 10(3). PMC: 8003070. DOI: 10.3390/antiox10030480. View

Sifuentes-Franco S, Padilla-Tejeda D, Carrillo-Ibarra S, Miranda-Diaz A . Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy. Int J Endocrinol. 2018; 2018:1875870. PMC: 5902001. DOI: 10.1155/2018/1875870. View

Zhang X, Li J, Yang B, Leng Q, Li J, Wang X . Alleviation of Liver Dysfunction, Oxidative Stress, and Inflammation Underlines the Protective Effects of Polysaccharides from Cordyceps cicadae on High Sugar/High Fat Diet-Induced Metabolic Syndrome in Rats. Chem Biodivers. 2021; 18(5):e2100065. DOI: 10.1002/cbdv.202100065. View

Yu S, Dubey N, Li W, Liu M, Chiang H, Leu S . Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice. PLoS One. 2016; 11(11):e0166342. PMC: 5104498. DOI: 10.1371/journal.pone.0166342. View

Dorotea D, Cho A, Lee G, Kwon G, Lee J, Sahu P . Orally active, species-independent novel A adenosine receptor antagonist protects against kidney injury in db/db mice. Exp Mol Med. 2018; 50(4):1-14. PMC: 5938017. DOI: 10.1038/s12276-018-0053-x. View

10.

Ma L, Wu F, Shao Q, Chen G, Xu L, Lu F . Baicalin Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy via Nrf2 and MAPK Signaling Pathway. Drug Des Devel Ther. 2021; 15:3207-3221. PMC: 8313380. DOI: 10.2147/DDDT.S319260. View

11.

Baker M, Davis S, Liu P, Pan X, Williams A, Iczkowski K . Tissue-Specific MicroRNA Expression Patterns in Four Types of Kidney Disease. J Am Soc Nephrol. 2017; 28(10):2985-2992. PMC: 5619963. DOI: 10.1681/ASN.2016121280. View

12.

Ren H, Wang Q . Non-Coding RNA and Diabetic Kidney Disease. DNA Cell Biol. 2021; 40(4):553-567. DOI: 10.1089/dna.2020.5973. View

13.

Gil C, Hooker E, Larrivee B . Diabetic Kidney Disease, Endothelial Damage, and Podocyte-Endothelial Crosstalk. Kidney Med. 2021; 3(1):105-115. PMC: 7873832. DOI: 10.1016/j.xkme.2020.10.005. View

14.

Zhu R, Chen Y, Deng Y, Zheng R, Zhong Y, Wang L . Cordyceps cicadae extracts ameliorate renal malfunction in a remnant kidney model. J Zhejiang Univ Sci B. 2011; 12(12):1024-33. PMC: 3232436. DOI: 10.1631/jzus.B1100034. View

15.

Wang W, Sun W, Cheng Y, Xu Z, Cai L . Role of sirtuin-1 in diabetic nephropathy. J Mol Med (Berl). 2019; 97(3):291-309. PMC: 6394539. DOI: 10.1007/s00109-019-01743-7. View

16.

Pan Z, Yang K, Wang H, Xiao Y, Zhang M, Yu X . MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways. FASEB J. 2020; 34(11):14250-14263. DOI: 10.1096/fj.202001026R. View

17.

Mao L, Liu S, Hu L, Jia L, Wang H, Guo M . miR-30 Family: A Promising Regulator in Development and Disease. Biomed Res Int. 2018; 2018:9623412. PMC: 5996469. DOI: 10.1155/2018/9623412. View

18.

Barutta F, Bellini S, Mastrocola R, Bruno G, Gruden G . MicroRNA and Microvascular Complications of Diabetes. Int J Endocrinol. 2018; 2018:6890501. PMC: 5863305. DOI: 10.1155/2018/6890501. View

19.

He Y, Lang X, Cheng D, Zhang T, Yang Z, Xiong R . miR‑30a‑5p inhibits hypoxia/reoxygenation‑induced oxidative stress and apoptosis in HK‑2 renal tubular epithelial cells by targeting glutamate dehydrogenase 1 (GLUD1). Oncol Rep. 2020; 44(4):1539-1549. PMC: 7448462. DOI: 10.3892/or.2020.7718. View

20.

Tian H, Lian R, Li Y, Liu C, Liang S, Li W . AKT-induced lncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent Vimentin degradation. Nat Commun. 2020; 11(1):5127. PMC: 7550350. DOI: 10.1038/s41467-020-18929-0. View